Evidence map›Paper›PMID 31947553›Full record

ArticleCancers2020

Selective Targeting of Cancer Stem Cells (CSCs) Based on Photodynamic Therapy (PDT) Penetration Depth Inhibits Colon Polyp Formation in Mice.

Jun Ki Kim, Mi Ran Byun, Chi Hoon Maeng, Yi Rang Kim, Jin Woo Choi

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Application of phototherapeutic-based nanoparticles in colorectal cancer.International journal of biological sciences · 2021
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Jun Ki KimBiomedical Engineering Research Center, Asan Institute for Life Sciences, Asan Medical Center, Seoul 05505, Korea.
Mi Ran ByunDepartment of Pharmacology, College of Pharmacy, Kyung Hee University, Seoul 02447, Korea.
Chi Hoon MaengDepartment of Hemato-Oncology, College of Medicine, Kyung Hee University, Seoul 02447, Korea.
Yi Rang KimDepartment of Hemato-Oncology, Yuseong Sun Hospital, Daejeon 34084, Korea.
Jin Woo ChoiDepartment of Pharmacology, College of Pharmacy, Kyung Hee University, Seoul 02447, Korea.
Kyung Hee University · KRDaejeon Sun Hospital · KRUlsan College · KR

Funding

Korea Health Industry Development Institute HA17C0039Korea Health Industry Development Institute HI18C2391Ministry of Trade, Industry and Energy 10080726Ministry of Trade, Industry and Energy 20000843National Research Foundation of Korea 2016R1D1A1B03930490National Research Foundation of Korea 2017R1A5A2014768National Research Foundation of Korea 2017R1C1B5017615National Research Foundation of Korea 2018R1A5A2020732National Research Foundation of Korea 2019R1A2C2084122
6 · The paper itself

Abstract

Targeting cancer stem cells (CSCs) without damaging normal stem cells could contribute to the development of novel radical cancer therapies. Cells expressing leucine-rich repeat-containing G-protein coupled receptor 5 (Lgr5) constitute a cancer-causing population in the colon; therefore, targeting of Lgr5+ cells is expected to provide an opportunity to mitigate colon cancer. However, the expression of Lgr5 in normal stem cells makes it difficult to prove the efficacy of therapies targeted exclusively at Lgr5+ cancer cells. We used a modified photodynamic therapy technique involving cellular radiative transfer between green fluorescent protein (GFP)-expressing cells and a rose bengal photosensitizer. After treatment, tumors containing GFP-Lgr5+ cells were observed to be significantly suppressed or retarded with little effect on GFP-Lgr5+ stem cells at the crypt bottom. Lgr5+ CSCs were specifically eradicated in situ, when localized based on the depth from the colon lumen, revealing the potential preventive efficacy of Lgr5-targeted therapy on tumor growth. This study supports the idea that Lgr5+ cells localized near the colon luminal surface are central to colorectal cancer. With further development, the targeting of localized Lgr5+ cancer stem cells, which this study demonstrates in concept, may be feasible for prevention of colon cancer in high-risk populations.

Indexed as

cancer stem cellscolon cancergreen fluorescent proteinphotodynamic therapyrose bengal photosensitizers

Identifiers

PMID31947553
PMCPMC7017170
OpenAlexW2999137338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.